These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. In vivo antileishmanial efficacy of miltefosine against Leishmania (Leishmania) amazonensis. García Bustos MF; Barrio A; Prieto GG; de Raspi EM; Cimino RO; Cardozo RM; Parada LA; Yeo M; Soto J; Uncos DA; Parodi C; Basombrío MA J Parasitol; 2014 Dec; 100(6):840-7. PubMed ID: 25014108 [TBL] [Abstract][Full Text] [Related]
23. In vivo activity of perifosine against Leishmania amazonensis. Cabrera-Serra MG; Valladares B; Piñero JE Acta Trop; 2008 Oct; 108(1):20-5. PubMed ID: 18801328 [TBL] [Abstract][Full Text] [Related]
24. Photodynamic therapy offers a novel approach to managing miltefosine-resistant cutaneous leishmaniasis. Cabral FV; Riahi M; Persheyev S; Lian C; Cortez M; Samuel IDW; Ribeiro MS Biomed Pharmacother; 2024 Aug; 177():116881. PubMed ID: 38917757 [TBL] [Abstract][Full Text] [Related]
25. In vitro evaluation of (-)α-bisabolol as a promising agent against Leishmania amazonensis. Rottini MM; Amaral AC; Ferreira JL; Silva JR; Taniwaki NN; Souza Cda S; d'Escoffier LN; Almeida-Souza F; Hardoim Dde J; Gonçalves da Costa SC; Calabrese Kda S Exp Parasitol; 2015 Jan; 148():66-72. PubMed ID: 25448354 [TBL] [Abstract][Full Text] [Related]
26. Efficacy of the 7-chloro-4-(3-hydroxy-benzilidenehydrazo)quinoline derivative against infection caused by Leishmania amazonensis. Antinarelli LMR; Souza MVN; Coelho EAF; Lima WP; Coimbra ES Rev Soc Bras Med Trop; 2020; 53():e20200091. PubMed ID: 32578713 [TBL] [Abstract][Full Text] [Related]
27. Aryl thiosemicarbazones: In vitro and immunomodulatory activities against L. amazonensis. da Silva AC; Dos Santos TAR; da Silva IVB; de Oliveira MVG; Moreira DRM; Leite ACL; Pereira VRA Exp Parasitol; 2017 Jun; 177():57-65. PubMed ID: 28433563 [TBL] [Abstract][Full Text] [Related]
33. Activity of paromomycin against Leishmania amazonensis: Direct correlation between susceptibility in vitro and the treatment outcome in vivo. Coser EM; Ferreira BA; Branco N; Yamashiro-Kanashiro EH; Lindoso JAL; Coelho AC Int J Parasitol Drugs Drug Resist; 2020 Dec; 14():91-98. PubMed ID: 33011651 [TBL] [Abstract][Full Text] [Related]
34. Efficacy of tamoxifen and miltefosine combined therapy for cutaneous leishmaniasis in the murine model of infection with Leishmania amazonensis. Trinconi CT; Reimão JQ; Coelho AC; Uliana SR J Antimicrob Chemother; 2016 May; 71(5):1314-22. PubMed ID: 26851606 [TBL] [Abstract][Full Text] [Related]
35. Efficacy of Apigenin and Miltefosine Combination Therapy against Experimental Cutaneous Leishmaniasis. Emiliano YSS; Almeida-Amaral EE J Nat Prod; 2018 Aug; 81(8):1910-1913. PubMed ID: 30095915 [TBL] [Abstract][Full Text] [Related]
36. In vitro activity of the hydroethanolic extract and biflavonoids isolated from Selaginella sellowii on Leishmania (Leishmania) amazonensis. Rizk YS; Fischer A; Cunha Mde C; Rodrigues PO; Marques MC; Matos Mde F; Kadri MC; Carollo CA; Arruda CC Mem Inst Oswaldo Cruz; 2014 Dec; 109(8):1050-6. PubMed ID: 25591109 [TBL] [Abstract][Full Text] [Related]
37. Effect of 1,2,3-triazole salts, non-classical bioisosteres of miltefosine, on Leishmania amazonensis. Stroppa PHF; Antinarelli LMR; Carmo AML; Gameiro J; Coimbra ES; da Silva AD Bioorg Med Chem; 2017 Jun; 25(12):3034-3045. PubMed ID: 28433512 [TBL] [Abstract][Full Text] [Related]
38. Novel benzoxaborole, nitroimidazole and aminopyrazoles with activity against experimental cutaneous leishmaniasis. Van Bocxlaer K; Caridha D; Black C; Vesely B; Leed S; Sciotti RJ; Wijnant GJ; Yardley V; Braillard S; Mowbray CE; Ioset JR; Croft SL Int J Parasitol Drugs Drug Resist; 2019 Dec; 11():129-138. PubMed ID: 30922847 [TBL] [Abstract][Full Text] [Related]
39. Chemical Characterization, Antileishmanial Activity, and Cytotoxicity Effects of the Essential Oil from Leaves of Pluchea carolinensis (Jacq.) G. Don. (Asteraceae). García M; Scull R; Satyal P; Setzer WN; Monzote L Phytother Res; 2017 Sep; 31(9):1419-1426. PubMed ID: 28703380 [TBL] [Abstract][Full Text] [Related]
40. Influence of long-term treatment with pravastatin on the survival, evolution of cutaneous lesion and weight of animals infected by Leishmania amazonensis. Kückelhaus CS; Kückelhaus SA; Muniz-Junqueira MI Exp Parasitol; 2011 Mar; 127(3):658-64. PubMed ID: 21176775 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]